Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

482
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

148
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

THROMBOTIC THROMBOCYTOPENIC PURPURA ASSOCIATED WITH CLOPIDOGREL : A CASE REPORT AND REVIEW OF THE LITERATURE

Pages

  352-357

Keywords

THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) 

Abstract

 Thrombotic Thrombocytopenic Purpura (TTP) is a life threatening, multisystem disease characterized by thrombocytopenia, microangiopathic hemolytic anemia, neurological changes, renal failure, and fever. These signs and symptoms are thought to be caused by microthrombi, composed of agglutinated platelets and fibrin, which deposit in the arterioles and capillaries without mediation by an inflammatory process. TTP can occur in the first two weeks of initiation of CLOPIDOGREL therapy. Early signs of TTP may be a skin reaction, which may precede the onset of TTP or it may be other type of purpura or neurological changes. We report the clinical and laboratory findings in a 67 years old female patient in whom TTP developed soon after treatment with 40 mg/day oral CLOPIDOGREL after 8 days. She developed thrombocytopenia (platelets count 12000 /mm3). Her clinical signs and symptoms were fever (39.6C), bleeding from the nose and gum, large skin bruises (purpura and ecchymoses), neurological changes including hallucinations, bizarre behavior, altered mental status (fluctuating), headache, and renal dysfunction. Physicians should be aware of the possibility early onset of this syndrome when initiate CLOPIDOGREL treatment.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    AZARM, TALEB, SOHRABI, AYATOLLAH, MOHAJER, HAMID, & AZARM, AREZOU. (2011). THROMBOTIC THROMBOCYTOPENIC PURPURA ASSOCIATED WITH CLOPIDOGREL : A CASE REPORT AND REVIEW OF THE LITERATURE. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), 16(3), 352-357. SID. https://sid.ir/paper/572742/en

    Vancouver: Copy

    AZARM TALEB, SOHRABI AYATOLLAH, MOHAJER HAMID, AZARM AREZOU. THROMBOTIC THROMBOCYTOPENIC PURPURA ASSOCIATED WITH CLOPIDOGREL : A CASE REPORT AND REVIEW OF THE LITERATURE. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS)[Internet]. 2011;16(3):352-357. Available from: https://sid.ir/paper/572742/en

    IEEE: Copy

    TALEB AZARM, AYATOLLAH SOHRABI, HAMID MOHAJER, and AREZOU AZARM, “THROMBOTIC THROMBOCYTOPENIC PURPURA ASSOCIATED WITH CLOPIDOGREL : A CASE REPORT AND REVIEW OF THE LITERATURE,” JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), vol. 16, no. 3, pp. 352–357, 2011, [Online]. Available: https://sid.ir/paper/572742/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top